Syros Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective r…

Biotechnology
US, Cambridge [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of SYRS's Analysis
CIK: 1556263 CUSIP: 87184Q107 ISIN: US87184Q2066 LEI: - UEI: -
Secondary Listings
SYRS has no secondary listings inside our databases.